Sunday, May 10, 2026

RCM AI firm Adonis is expanding its footprint in the healthcare revenue cycle market through strategic appearances at HFMA events and AI conferences. The move signals continued investment in automated billing and denial management tools by third-party vendors. For independent practices, this represents a growing ecosystem of point solutions aiming to address payer complexity, but also a crowded vendor landscape that requires careful evaluation.

Federal investigators uncovered a $522 million genetic testing fraud scheme targeting Medicare and Medicaid. The operation involved fraudulent billing for unnecessary tests. This enforcement action will trigger heightened audit scrutiny for all molecular and genetic testing claims. Review your lab ordering and documentation protocols immediately. Ensure all genetic test claims have robust medical necessity documentation signed by the treating physician, not a third-party marketer.

States are spending millions to overhaul their Medicaid systems in preparation for potential federal funding changes, with analysts warning the transition could cause coverage losses. The preparations, driven by anticipated shifts in the federal matching rate or block grant proposals, require complex updates to eligibility and enrollment IT systems. The risk is that during these transitions, eligible individuals, particularly in renewal processing, may fall through the cracks and lose coverage due to administrative hurdles, not a change in eligibility. For practices, this signals impending administrative chaos: expect increased patient confusion over coverage status, more front-desk eligibility verification work, and a potential rise in uncompensated care if patients are incorrectly disenrolled. Monitor your state Medicaid agency's communications about system changeover dates.